Status:
TERMINATED
Integrating Acupuncture Into the Management of Migraines
Lead Sponsor:
National University of Health Sciences
Conditions:
Migraine Headache
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This research is being done to study the effect of incorporating acupuncture into the management of migraines. The primary aim is to determine in a randomized, controlled study whether individuals exp...
Detailed Description
70 men and women between the ages of 18-65 diagnosed with migraines by a medical doctor. Participants must be using only nonprescription medication to treat their head pain. Once initial eligibility ...
Eligibility Criteria
Inclusion
- Migraine with or without aura according to the International Headache Society classification and diagnosed by a Medical Doctor.
- Subjects are required to have between 2 and 12 migraines but no more than 15 headache days (migraine or nonmigraine) per 28 days during the prospective baseline phase. A headache day is defined as a calendar day during which the patient experienced headache for at least 30 minutes.
- Taking a nonprescription medication for the migraine pain. More specifically Aspirin, Ibuprofen, Naproxen, and/or Acetaminophen (with or without caffeine).
- Age between 18 and 65 years.
- A history of migraine for at least 12 months.
- Completed at least 75% of the baseline headache diary.
- Completion of written informed consent.
Exclusion
- Onset of headache disorder less than 12 months prior to age 50.
- Pregnancy or planning to get pregnant while participating in the study.
- Malignancy; cluster headache (IHS code 3); sinus headaches.
- Suspicion that headache disorder has specific etiology (IHS code 5-11); cranial neuralgias (IHS code12)
- Acupuncture treatment in the previous 12 months.
- Taking a prescription medication for the migraine pain.
- Subject plans to receive acupuncture for another medical condition while participating in the study.
- Systemic disorder or illness, including serious psychiatric illness.
- Failure to fulfill baseline information.
- Failure to provide written informed consent.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT01481103
Start Date
July 1 2011
End Date
April 1 2013
Last Update
April 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Serenity Acupuncture and Oriental Medicine
Oak Park, Illinois, United States, 60302